Back
Krystal Biotech Vs. Axsome Therapeutics Industry Stock Comparison
Sell
40
KRYS
Krystal Biotech
Last Price:
163.99
Seasonality Move:
17.64%
Buy
63
AXSM
Axsome Therapeutics
Last Price:
76.54
Seasonality Move:
-2.29%
Sell
40
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $163.78. The Score for KRYS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $77.35. The Score for AXSM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $163.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $77.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.41 | Sell |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 37905 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (155.62 - 165.96) | Buy |
| Bollinger Bands (100): | (122.45 - 172.13) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 57.54 | Buy |
| Chaikin Money Flow: | 382419 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.66 - 75.98) | Buy |
| Bollinger Bands (100): | (71.84 - 88.08) | Sell |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 159.28 | Buy |
| 20-day SMA: | 158.64 | Buy |
| 50-day SMA: | 167.67 | Sell |
| 200-day SMA: | 130.9 | Buy |
| 8-day EMA: | 160.09 | Buy |
| 20-day EMA: | 160.84 | Buy |
| 50-day EMA: | 159.51 | Buy |
| 200-day EMA: | 135.28 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.64 | Buy |
| 20-day SMA: | 73.94 | Buy |
| 50-day SMA: | 73.63 | Buy |
| 200-day SMA: | 74.77 | Buy |
| 8-day EMA: | 75.75 | Buy |
| 20-day EMA: | 74.56 | Buy |
| 50-day EMA: | 75.09 | Buy |
| 200-day EMA: | 74.67 | Buy |
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.66 per share, an increase next quarter of $0.28 per share, an increase this year of $3.59 per share, and an increase next year of $2.08 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.51 per share, a decrease this year of $0.56 per share, and an increase next year of $4.02 per share.
Krystal Biotech Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||